Gemmer Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Gemmer Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$3K	–	1498
2021 Q1	$3K	Buy	+300	New	+$3.56K	﹤0.01%	1231

Other funds holding ACHV

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Gemmer Asset Management's ACHV Position: Q2 2021 in Review

Gemmer Asset Management sold out of Achieve Life Sciences (ACHV) in Q2 2021, closing a stake of 300 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in ACHV in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 29 funds tracked by Wall St. Rank hold ACHV as of Q2 2021.

Gemmer Asset Management reported no remaining Achieve Life Sciences position as of Q2 2021 after selling out during the quarter.
Gemmer Asset Management sold 300 Achieve Life Sciences shares in Q2 2021, an estimated $3K.
Gemmer Asset Management first reported a position in Achieve Life Sciences in Q1 2021 and held it in 1 quarter.
Gemmer Asset Management's Achieve Life Sciences position peaked at $3K in Q1 2021.
29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2021.

Based on Gemmer Asset Management's 13F filing for Q2 2021, filed 23 Jul 2021.